Journal of Medicinal Chemistry p. 2525 - 2533 (1992)
Update date:2022-07-30
Topics:
Tucker, Thomas J.
Lumma, William C.
Payne, Linda S.
Wai, Jenny M.
Solms, S. Jane de
et al.
A series of HIV-1 protease inhibitors containing a novel hydroxyethyl secondary amine transition state isostere has been synthesized.The compounds exhibit a strong preference for the (R) stereochemistry at the transition state hydroxyl group.Molecular modeling studies with the prototype compound 11 have provided important insights into the structural requirements for good inhibitor-active site binding interaction.N-Terminal extension of 11 into the P2-P3 region led to the discovery of 19, the most potent enzyme inhibitor in the series (IC50 = 5.4 nM). 19 was shown to have potent antiviral activity in cultured MT-4 human T-lymphoid cells.Comparison of analogs of 19 with analogs of 1 (Ro31-8959) demonstrates that considerably different structure-activity relationships exist between these two subclasses of hydroxyethylamine HIV-protease inhibitors.
View MoreJIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Contact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Contact:+86-570-4336358
Address:No.87 Building,Tianqian,Sidu Town
Zibo Fuxi'er Chemical Co.,Ltd (Shanxian Fuxi'er Chemical Co.,Ltd)
Contact:+86-533-2091422
Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Doi:10.1055/s-0032-1317700
(2013)Doi:10.1021/om00044a005
(1992)Doi:10.1016/j.cclet.2013.01.037
(2013)Doi:10.1016/j.bmcl.2012.12.010
(2013)Doi:10.1016/j.bioorg.2018.09.028
(2018)Doi:10.3390/molecules21030232
(2016)